scholarly journals An Analysis of the Risk Factors for the Failure of Respiratory Support With High-flow Nasal Cannula Oxygen Therapy in Children with Acute Respiratory Dysfunction:a case-control study

2020 ◽  
Author(s):  
jie liu ◽  
Li-na QIAO ◽  
De-yuan LI ◽  
Li-li LUO ◽  
Zhong-qiang LIU ◽  
...  
Keyword(s):  
Risk Factors ◽  
Pediatric Patients ◽  
Invasive Mechanical Ventilation ◽  
Oxygenation Index ◽  
High Flow ◽  
Respiratory Support ◽  
High Flow Nasal Cannula ◽  
Failure Group ◽  
Before And After ◽  
Change Trend

Abstract Background:Different causes of acute respiratory insufficiency threaten the lives of pediatric patients, while High-flow nasal cannula oxygen therapy (HFNC) is a new type of non-invasive respiratory support technique that widely used in pediatric intensive care units (PICUs);however, improper use of HFNC is likely to bring adverse consequences to critically ill children.Our objective in this study was to identify the risk factors for the failure of HFNC, that can guide clinicians during managing of HFNC treatment correctly.Methods: Divided the patients into different categories: HFNC success group (237 patients), a 48 h failure group (112 patients), a 24 h failure group (84 patients), and a 2 h failure group (24 patients). The clinical indexes and the change trend in HFNC before and after treatment were dynamically observed in 67 pediatric patients. Risk factors for HFNC failure were determined using multivariate logistic regression analysis.Results:PRISM III score >4 points and PaCO2 >43 mmHg were risk factors for 48 h failure (OR were 4.064, 4.516, P<0.05); PaCO2 >43 mmHg was risk factors for 24 h failure (OR was 3.152, P<0.05); PRISM III score >6.5 points and PaCO2/PaO2 ratio >0.67 were risk factors for 2 h failure (OR were 27.977, 64.366, P<0.05) and the risk of HFNC failure increased more than 5 times when the oxygenation index decreased by >28% after 2 h of HFNC treatment, and the invasive mechanical ventilation time was statistically longer in the patients that upgraded from HFNC to invasive respiratory support than that of patients who received invasive respiratory support directly(P<0.05).Conclusions: The PRISM III score, PaCO2 and PaCO2/PaO2 ratio were risk factors for HFNC failure. Totally the shorter the failure time, the higher the values of the risk factors were, and the higher the failure risk of HFNC was. The change trend in oxygenation index before and after HFNC is a warning factor for early HFNC failure. And early HFNC failure might lead to prolonged invasive mechanical ventilation.

scholarly journals An Analysis of the Risk Factors for the Failure of Respiratory Support With High-flow Nasal Cannula Oxygen Therapy in Children with Acute Respiratory Dysfunction: a case-control study

2021 ◽  
Author(s):  
Jie LIU ◽  
De-yuan LI ◽  
Li-li LUO ◽  
Zhong-qiang LIU ◽  
Xiao-qing LI ◽  
...  
Keyword(s):  
Risk Factors ◽  
Mechanical Ventilation ◽  
Oxygen Therapy ◽  
Failure Time ◽  
Invasive Mechanical Ventilation ◽  
Nasal Cannula ◽  
Respiratory Support ◽  
Failure Group ◽  
Before And After ◽  
Group A

Objective:High-flow nasal cannula oxygen therapy (HFNC) is a new type of non-invasive respiratory support technique that widely used in pediatric intensive care units (PICUs);however,improper use of HFNC is likely to bring adverse outcomes to critically ill children.Our objective of this study was to identify the risk factors for the failure of HFNC.Study design: Divided the patients into different categories: HFNC success group, a 48h failure group, a 24h failure group, and a 2h failure group.The clinical indexes and the change trend in HFNC before and after treatment were dynamically observed in 67 pediatric patients. Risk factors for HFNC failure were determined using multivariate logistic regression analysis.Results:PRISM III score>4 points and PaCO2>43 mmHg were risk factors for 48h failure (OR were 4.064, 4.516, P<0.05); PaCO2>43 mmHg was risk factors for 24 h failure (OR was 3.152, P<0.05); PRISM III score>6.5 points and PaCO2/PaO2 ratio>0.67 were risk factors for 2 h failure (OR were 27.977, 64.366, P<0.05) and the risk of HFNC failure increased more than 5 times when the PaO2/FiO2 ratio decreased by>28% after 2 h of HFNC treatment, and the invasive mechanical ventilation time was statistically longer in the patients that upgraded from HFNC to invasive respiratory support than that of patients who received invasive respiratory support directly(P<0.05).Conclusions:The PRISM III score, PaCO2 and PaCO2/PaO2 ratio were risk factors for HFNC failure.Totally the shorter the failure time, the higher the values of the risk factors were, and the higher the failure risk of HFNC was. The change in the PaO2/FiO2 ratio before and after HFNC is a warning indicator for early HFNC failure. And early HFNC failure might lead to prolonged invasive mechanical ventilation.

scholarly journals Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study

2020 ◽  
Author(s):  
Ming Hu ◽  
Qiang Zhou ◽  
Ruiqiang Zheng ◽  
Xuyan Li ◽  
Jianmin Ling ◽  
...  
Keyword(s):  
Saturation Index ◽  
Characteristic Curve ◽  
Treatment Success ◽  
Invasive Mechanical Ventilation ◽  
Multivariate Logistic Regression Analysis ◽  
Oxygenation Index ◽  
High Flow ◽  
Nasal Cannula ◽  
Respiratory Support ◽  
High Flow Nasal Cannula

Abstract Background: High-flow nasal cannula (HFNC) oxygen therapy provides effective respiratory support in patients with hypoxemic respiratory failure. However, the efficacy of HFNC for patients with COVID-19 has not been established. This study was performed to assess the efficacy of HFNC for patients with COVID-19 and describe early predictors of HFNC treatment success in order to develop a prediction tool that accurately identifies the need for invasive mechanical ventilation (IMV). Methods: We retrospectively reviewed the records of patients with COVID-19 who underwent HFNC in 2 hospitals in Wuhan between 1 January and 1 March 2020. Overall survival, the success rate of HFNC treatment and respiratory variables to predict the outcome of HFNC treatment were evaluated.Results: A total of 105 patients were analyzed. Of these, 65 patients (61.9%) showed improved oxygenation and were successfully withdrawn from HFNC. The oxygenation index (PaO2/FiO2), Oxygen saturation index (SpO2/FiO2) and respiratory rate-oxygenation index (ROX index: SpO2/FiO2*RR) at 6h, 12h and 24h of HFNC initiation were closely related to the prognosis. The best predictor was the ROX index at 24h after initiating HFNC (area under the receiver operating characteristic curve, 0.874). In the multivariate logistic regression analysis, young age, gender of female, and lower SOFA score all have predictive value, while a ROX index greater than 6.10 at 24 h after initiation was significantly associated with HFNC success (OR, 104.212; 95% CI, 11.399-952.757; p＜0.001).Conclusions: Our study indicated that HFNC was an effective way of respiratory support in the treatment of severe COVID-19. The ROX index greater than 6.10 at 24 h after initiating HFNC was a good predictor of successful HFNC treatment.

scholarly journals Protocolized Post-Extubation Respiratory Support to prevent reintubation: protocol and statistical analysis plan for a clinical trial

BMJ Open ◽  
2019 ◽  
Vol 9 (8) ◽  
pp. e030476 ◽  
Author(s):  
Jonathan Dale Casey ◽  
Erin R Vaughan ◽  
Bradley D Lloyd ◽  
Peter A Bilas ◽  
Eric J Hall ◽  
...  
Keyword(s):  
Mechanical Ventilation ◽  
Usual Care ◽  
Invasive Mechanical Ventilation ◽  
High Flow ◽  
Respiratory Support ◽  
Invasive Ventilation ◽  
High Flow Nasal Cannula ◽  
Non Invasive ◽  
Non Invasive Ventilation ◽  
Risk Patients

IntroductionFollowing extubation from invasive mechanical ventilation, nearly one in seven critically ill adults requires reintubation. Reintubation is independently associated with increased mortality. Postextubation respiratory support (non-invasive ventilation or high-flow nasal cannula applied at the time of extubation) has been reported in small-to-moderate-sized trials to reduce reintubation rates among hypercapnic patients, high-risk patients without hypercapnia and low-risk patients without hypercapnia. It is unknown whether protocolised provision of postextubation respiratory support to every patient undergoing extubation would reduce the overall reintubation rate, compared with usual care.Methods and analysisThe Protocolized Post-Extubation Respiratory Support (PROPER) trial is a pragmatic, cluster cross-over trial being conducted between 1 October 2017 and 31 March 2019 in the medical intensive care unit of Vanderbilt University Medical Center. PROPER compares usual care versus protocolized post-extubation respiratory support (a respiratory therapist-driven protocol that advises the provision of non-invasive ventilation or high-flow nasal cannula based on patient characteristics). For the duration of the trial, the unit is divided into two clusters. One cluster receives protocolised support and the other receives usual care. Each cluster crosses over between treatment group assignments every 3 months. All adults undergoing extubation from invasive mechanical ventilation are enrolled except those who received less than 12 hours of mechanical ventilation, have ‘Do Not Intubate’ orders, or have been previously reintubated during the hospitalisation. The anticipated enrolment is approximately 630 patients. The primary outcome is reintubation within 96 hours of extubation.Ethics and disseminationThe trial was approved by the Vanderbilt Institutional Review Board. The results will be submitted for publication in a peer-reviewed journal and presented at one or more scientific conferences.Trial registration numberNCT03288311.

scholarly journals High flow nasal cannula versus non-invasive ventilation in severe asthma: two years prospective observational study.

2021 ◽  
Author(s):  
Carolina Solé-Delgado ◽  
Alberto García-Salido ◽  
Ainhoa Gochi-Valdovinos ◽  
Anthony González-Brabin ◽  
Maria García ◽  
...  
Keyword(s):  
Observational Study ◽  
Severe Asthma ◽  
Prospective Observational Study ◽  
Invasive Mechanical Ventilation ◽  
High Flow ◽  
Nasal Cannula ◽  
Respiratory Support ◽  
High Flow Nasal Cannula ◽  
Non Invasive ◽  
Respiratory Management

Background: in recent years, High Flow Nasal Cannula (HFNC) has been considered an alternative to non-invasive mechanical ventilation (NIMV) in severe asthma respiratory management in children. Objective: to describe the use of HFNC in children with severe asthma admitted to pediatric critical care unit (PICU). To compare its clinical characteristic and evolution with those receiving NIMV or other respiratory support. Methods: prospective observational study done in children admitted to PICU with severe asthma (October 2017 to October 2019). Data collected: epidemiological, clinical, respiratory support, thorax x-ray, pharmacological treatments and days of admission. Patients were divided into groups: 1) Only HFNC 2) HFNC and NIMV, and 3) Only NIMV. Results: Seventy-six patients included, 39 girls. The median age was two years and one month (range 160). The median pulmonary score was 5 (range 7). PICU admission lengths a median of 3 days (range 9), hospital 6 days (range 23). There were no epidemiological or clinical differences between groups. Children with only HNFC showed a shorter time of PICU days (p 0,025) and none of them required NIMV. In the group receiving both modalities, NIMV was used first and then HFNC in all cases. Children with HFNC showed higher SaO2/FiO2 ratio (p=0,025) and lower PCO2 level (p=0,032). There were no deaths. Conclusions: in our study the HFNC did not require escalation to NIMV and did not increase the length of PICU or hospital days. Normal initial blood gases and absence of high oxygen requirements were useful to select responders to HNFC.

scholarly journals Association between preoperative respiratory support and outcomes in paediatric cardiac surgery

2019 ◽  
Vol 30 (1) ◽  
pp. 66-73
Author(s):  
Elizabeth C. Ciociola ◽  
Karan R. Kumar ◽  
Kanecia O. Zimmerman ◽  
Elizabeth J. Thompson ◽  
Melissa Harward ◽  
...  
Keyword(s):  
Mechanical Ventilation ◽  
Length Of Stay ◽  
Odds Ratio ◽  
Operative Mortality ◽  
Invasive Mechanical Ventilation ◽  
High Flow ◽  
Nasal Cannula ◽  
Respiratory Support ◽  
High Flow Nasal Cannula ◽  
Prolonged Length

AbstractBackground:Preoperative mechanical ventilation is associated with morbidity and mortality following CHD surgery, but prior studies lack a comprehensive analysis of how preoperative respiratory support mode and timing affects outcomes.Methods:We retrospectively collected data on children <18 years of age undergoing cardiac surgery at an academic tertiary care medical centre. Using multivariable regression, we examined the association between modes of preoperative respiratory support (nasal cannula, high-flow nasal cannula/noninvasive ventilation, or invasive mechanical ventilation), escalation of preoperative respiratory support, and invasive mechanical ventilation on the day of surgery for three outcomes: operative mortality, postoperative length of stay, and postoperative complications. We repeated our analysis in a subcohort of neonates.Results:A total of 701 children underwent 800 surgical procedures, and 40% received preoperative respiratory support. Among neonates, 243 patients underwent 253 surgical procedures, and 79% received preoperative respiratory support. In multivariable analysis, all modes of preoperative respiratory support, escalation in preoperative respiratory support, and invasive mechanical ventilation on the day of surgery were associated with increased odds of prolonged length of stay in children and neonates. Children (odds ratio = 3.69, 95% CI 1.2–11.4) and neonates (odds ratio = 8.97, 95% CI 1.31–61.14) on high-flow nasal cannula/noninvasive ventilation had increased odds of operative mortality compared to those on room air.Conclusion:Preoperative respiratory support is associated with prolonged length of stay and mortality following CHD surgery. Knowing how preoperative respiratory support affects outcomes may help guide surgical timing, inform prognostic conversations, and improve risk stratification models.

scholarly journals The Role of Heated Humidified High-flow Nasal Cannula as Noninvasive Respiratory Support in Neonates

2017 ◽  
Vol 58 (4) ◽  
pp. 295-302 ◽  
Author(s):  
Ke-Yun Chao ◽  
Yi-Ling Chen ◽  
Li-Yi Tsai ◽  
Yu-Hsuan Chien ◽  
Shu-Chi Mu
Keyword(s):  
High Flow ◽  
Nasal Cannula ◽  
Respiratory Support ◽  
High Flow Nasal Cannula
Sign in / Sign up

Export Citation Format

Share Document